We are live on ! Find out more
AI

Acuitas Investments Portfolio holdings

AUM $1.43M
1-Year Est. Return 17.52%
This Fund
S&P 500
This Quarter Est. Return
-2.08%
1 Year Est. Return
+17.52%
3 Year Est. Return
+145.17%
5 Year Est. Return
+267.61%
10 Year Est. Return
AUM
$187M
AUM Growth
-$11.4M
Cap. Flow
-$2.13M
Cap. Flow %
-1.14%
Top 10 Hldgs %
23.98%
Holding
134
New
11
Increased
53
Reduced
26
Closed
16

Sector Composition

Rank Sector Weight
1 Industrials 16.87%
2 Healthcare 16.68%
3 Consumer Discretionary 15.21%
4 Technology 11.89%
5 Energy 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVIR icon
76
Atea Pharmaceuticals
AVIR
$420M
$858K 0.46%
259,289
+1,379
+0.5% +$5.14K
VOXX
77
DELISTED
VOXX International Corporation Class A
VOXX
$855K 0.46%
+270,711
New +$1.44M
SSTI icon
78
SoundThinking
SSTI
$103M
$850K 0.45%
69,749
-20,878
-23% -$297K
FTEK icon
79
Fuel Tech
FTEK
$43.7M
$835K 0.45%
780,746
+4,132
+0.5% +$4.79K
GENC icon
80
Gencor Industries
GENC
$212M
$767K 0.41%
39,652
-38,844
-49% -$714K
NTGR icon
81
NETGEAR
NTGR
$635M
$724K 0.39%
47,312
+250
+0.5% +$3.5K
KLRS
82
Kalaris Therapeutics
KLRS
$96.8M
$712K 0.38%
42,819
+228
+0.5% +$4.03K
GIFI
83
DELISTED
Gulf Island Fabrication
GIFI
$703K 0.38%
115,861
-119,228
-51% -$801K
ASMB icon
84
Assembly Biosciences
ASMB
$529M
$686K 0.37%
49,996
+264
+0.5% +$3.77K
AXR icon
85
AMREP Corp
AXR
$119M
$661K 0.35%
34,980
+189
+0.5% +$3.89K
IMA
86
ImageneBio Inc
IMA
$64.6M
$660K 0.35%
33,323
+177
+0.5% +$3.13K
TATT icon
87
TAT Technologies
TATT
$515M
$631K 0.34%
42,275
-12,435
-23% -$164K
OKUR
88
OnKure Therapeutics
OKUR
$168M
$613K 0.33%
40,621
+216
+0.5% +$3.66K
KZR
89
DELISTED
Kezar Life Sciences
KZR
$592K 0.32%
98,679
+29,596
+43% +$225K
AIP icon
90
Arteris
AIP
$1.38B
$578K 0.31%
76,977
-160,787
-68% -$1.22M
PMVP icon
91
PMV Pharmaceuticals
PMVP
$63.5M
$573K 0.31%
353,749
+1,874
+0.5% +$3.38K
SEER icon
92
Seer Inc
SEER
$120M
$572K 0.31%
340,750
+1,801
+0.5% +$3.36K
CMRX
93
DELISTED
Chimerix, Inc.
CMRX
$559K 0.3%
638,657
+3,396
+0.5% +$3.22K
KRON
94
DELISTED
Kronos Bio
KRON
$550K 0.29%
443,457
+2,351
+0.5% +$2.39K
ASTC icon
95
Astrotech Corp
ASTC
$17.8M
$536K 0.29%
59,546
+309
+0.5% +$2.88K
ADAP
96
DELISTED
Adaptimmune Therapeutics
ADAP
$528K 0.28%
541,201
+2,880
+0.5% +$3.16K
WHWK
97
Whitehawk Therapeutics
WHWK
$271M
$515K 0.28%
352,483
+34,344
+11% +$63.6K
NXTC icon
98
NextCure
NXTC
$26.7M
$514K 0.28%
26,945
+140
+0.5% +$2.72K
ACRS icon
99
Aclaris Therapeutics
ACRS
$869M
$511K 0.27%
464,120
+2,457
+0.5% +$2.89K
TRAK icon
100
ReposiTrak
TRAK
$159M
$498K 0.27%
+32,600
New +$525K

Similar funds

Acuitas Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Acuitas Investments held 134 positions worth $187M, down 5.7% from $198M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Acuitas Investments's Q2 2024 filing shows 11 new, 53 increased, 26 reduced and 16 closed positions. Its largest new stake was Uranium Royalty Corp: 942,109 shares worth $2.12M. The largest sale was Trekor Metals, an estimated $3.5M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Acuitas Investments's largest Q2 2024 buy was Uranium Royalty Corp: 942,109 shares worth $2.12M.
  • Acuitas Investments added most to Hurco Companies Inc in Q2 2024, an estimated $1.47M increase.
  • Acuitas Investments's biggest Q2 2024 reduction was Trekor Metals, cutting an estimated $3.5M.
  • Acuitas Investments fully exited Overseas Shipholding Group Inc. in Q2 2024, selling an estimated $2.82M.
  • Acuitas Investments's ten largest holdings make up 24% of its $187M portfolio in Q2 2024.
  • Acuitas Investments opened 11 new positions and closed 16 in Q2 2024.
  • Acuitas Investments's portfolio value fell 5.7% quarter-over-quarter to $187M.

Based on Acuitas Investments's 13F filing for Q2 2024, filed 5 Aug 2024.